Led Hovione’s RD Particle Design group between 2006 and 2012 and was involved in +120 projects. Lead Scientist in four projects that reached commercial stage, including the first at Hovione submitted under QbD.
In 2012 he became the Director of Drug Product Technologies with responsibility for selection and implementation of new
technologies.Since August 2013 he is the business leader for Particle Engineering Services.His areas of interest include Particle Engineering, Quality by Design, Industrial Marketing and Business Development.
Read More